Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Anticancer efficacy of KRASG12C inhibitors is potentiated... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers
0
Authors
Husain Khan
19 more
Husain Khan
•
Misako Nagasaka
17 more
•
Asfar Azmi
Published
March 27, 2023
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Biochemistry
Chemistry
Medicine
Cancer Oncology
Show all topics
DOI
10.1101/2023.03.27.534309
License
cc-no
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Biochemistry
Chemistry
Medicine
Cancer Oncology
Show all topics
DOI
10.1101/2023.03.27.534309
License
cc-no
